127 related articles for article (PubMed ID: 8892783)
1. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency.
Vlietstra RE; Nunn CM; Narvarte J; Browne KF
Am Heart J; 1996 Nov; 132(5):1049-50. PubMed ID: 8892783
[No Abstract] [Full Text] [Related]
2. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
3. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
4. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
[TBL] [Abstract][Full Text] [Related]
6. Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy.
Danenberg HD; Lotan C; Varshitski B; Rosenheck S; Weiss AT
Cardiovasc Revasc Med; 2008; 9(1):9-13. PubMed ID: 18206631
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Kane GC; Doyle BJ; Lerman A; Barsness GW; Best PJ; Rihal CS
J Am Coll Cardiol; 2008 Jan; 51(1):89-90. PubMed ID: 18174044
[No Abstract] [Full Text] [Related]
8. Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.
Angoulvant D; Cucherat M; Rioufol G; Finet G; Beaune J; Revel D; Laville M; Ovize M; André-Fouët X
Arch Cardiovasc Dis; 2009 Nov; 102(11):761-7. PubMed ID: 19944392
[TBL] [Abstract][Full Text] [Related]
9. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Huber W; Ilgmann K; Page M; Hennig M; Schweigart U; Jeschke B; Lutilsky L; Weiss W; Salmhofer H; Classen M
Radiology; 2002 Jun; 223(3):772-9. PubMed ID: 12034949
[TBL] [Abstract][Full Text] [Related]
10. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Stone GW; McCullough PA; Tumlin JA; Lepor NE; Madyoon H; Murray P; Wang A; Chu AA; Schaer GL; Stevens M; Wilensky RL; O'Neill WW;
JAMA; 2003 Nov; 290(17):2284-91. PubMed ID: 14600187
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
Aslanger E; Uslu B; Akdeniz C; Polat N; Cizgici Y; Oflaz H
Coron Artery Dis; 2012 Jun; 23(4):265-70. PubMed ID: 22343798
[TBL] [Abstract][Full Text] [Related]
12. Differential survival after coronary revascularization procedures among patients with renal insufficiency.
Szczech LA; Reddan DN; Owen WF; Califf R; Racz M; Jones RH; Hannan EL
Kidney Int; 2001 Jul; 60(1):292-9. PubMed ID: 11422764
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.
Miner SE; Dzavik V; Nguyen-Ho P; Richardson R; Mitchell J; Atchison D; Seidelin P; Daly P; Ross J; McLaughlin PR; Ing D; Lewycky P; Barolet A; Schwartz L
Am Heart J; 2004 Oct; 148(4):690-5. PubMed ID: 15459602
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
Huber W; Schipek C; Ilgmann K; Page M; Hennig M; Wacker A; Schweigart U; Lutilsky L; Valina C; Seyfarth M; Schömig A; Classen M
Am J Cardiol; 2003 May; 91(10):1157-62. PubMed ID: 12745095
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy is not preventable.
Chambers CE
Catheter Cardiovasc Interv; 2012 Jan; 79(1):76-7. PubMed ID: 22190207
[No Abstract] [Full Text] [Related]
17. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
Deray G
J Am Coll Cardiol; 2007 Apr; 49(15):1668. PubMed ID: 17433961
[No Abstract] [Full Text] [Related]
18. Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?
Kefer JM; Hanet CE; Boitte S; Wilmotte L; De Kock M
Acta Cardiol; 2003 Dec; 58(6):555-60. PubMed ID: 14713182
[TBL] [Abstract][Full Text] [Related]
19. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
Persson P; Liss P; Hansell P
J Am Coll Cardiol; 2007 Apr; 49(15):1668-1669. PubMed ID: 17433962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
